Boston Research & Management’s iShares Core MSCI Emerging Markets ETF IEMG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.35M Sell
100,742
-2,564
-2% -$204K 1.84% 15
2026
Q1
$7.21M Sell
103,306
-576
-0.6% -$41.6K 1.68% 20
2025
Q4
$6.98M Sell
103,882
-3,120
-3% -$209K 1.59% 20
2025
Q3
$7.05M Sell
107,002
-175
-0.2% -$10.9K 1.54% 23
2025
Q2
$6.43M Buy
107,177
+1,690
+2% +$94.3K 1.52% 21
2025
Q1
$5.69M Buy
105,487
+545
+0.5% +$29.3K 1.41% 26
2024
Q4
$5.48M Buy
104,942
+1,319
+1% +$73K 1.35% 29
2024
Q3
$5.95M Buy
103,623
+1,736
+2% +$94K 1.4% 29
2024
Q2
$5.45M Buy
101,887
+737
+0.7% +$38.9K 1.38% 27
2024
Q1
$5.22M Sell
101,150
-748
-0.7% -$37.5K 1.29% 35
2023
Q4
$5.15M Buy
101,898
+3,306
+3% +$160K 1.37% 31
2023
Q3
$4.69M Buy
98,592
+467
+0.5% +$23.1K 1.39% 26
2023
Q2
$4.84M Sell
98,125
-735
-0.7% -$35.9K 1.37% 29
2023
Q1
$4.82M Buy
98,860
+1,986
+2% +$97.4K 1.44% 26
2022
Q4
$4.52M Buy
96,874
+1,130
+1% +$51.4K 1.4% 30
2022
Q3
$4.12M Sell
95,744
-4,281
-4% -$205K 1.4% 30
2022
Q2
$4.91M Buy
100,025
+3,973
+4% +$205K 1.59% 24
2022
Q1
$5.33M Sell
96,052
-410
-0.4% -$23.7K 1.55% 21
2021
Q4
$5.77M Buy
96,462
+85
+0.1% +$5.25K 1.58% 24
2021
Q3
$5.95M Buy
96,377
+3,576
+4% +$228K 1.77% 20
2021
Q2
$6.22M Buy
92,801
+1,763
+2% +$116K 1.89% 17
2021
Q1
$5.86M Buy
91,038
+1,095
+1% +$72K 1.89% 17
2020
Q4
$5.58M Buy
89,943
+1,805
+2% +$104K 1.94% 17
2020
Q3
$4.65M Sell
88,138
-742
-0.8% -$38.9K 1.82% 20
2020
Q2
$4.23M Buy
88,880
+6,634
+8% +$296K 1.76% 20
2020
Q1
$3.33M Sell
82,246
-11,314
-12% -$556K 1.67% 27
2019
Q4
$5.03M Sell
93,560
-348
-0.4% -$17.9K 1.89% 19
2019
Q3
$4.6M Buy
93,908
+3,894
+4% +$193K 1.82% 21
2019
Q2
$4.63M Buy
90,014
+4,195
+5% +$214K 1.87% 18
2019
Q1
$4.44M Sell
85,819
-222
-0.3% -$11.2K 1.85% 19
2018
Q4
$4.06M Buy
86,041
+3,431
+4% +$166K 1.93% 20
2018
Q3
$4.28M Buy
82,610
+7,000
+9% +$365K 1.95% 16
2018
Q2
$3.97M Buy
75,610
+216
+0.3% +$12.1K 1.95% 13
2018
Q1
$4.4M Buy
75,394
+1,786
+2% +$106K 2.24% 8
2017
Q4
$4.19M Sell
73,608
-1,267
-2% -$70.7K 2.1% 12
2017
Q3
$4.04M Buy
74,875
+497
+0.7% +$26.4K 2.07% 13
2017
Q2
$3.72M Buy
74,378
+498
+0.7% +$24.6K 2.01% 13
2017
Q1
$3.53M Buy
73,880
+2,893
+4% +$133K 1.92% 15
2016
Q4
$3.01M Sell
70,987
-298
-0.4% -$13.1K 1.71% 28
2016
Q3
$3.25M Buy
71,285
+1,422
+2% +$63.1K 1.88% 18
2016
Q2
$2.92M Buy
69,863
+16,286
+30% +$667K 1.77% 24
2016
Q1
$2.23M Buy
53,577
+28,487
+114% +$1.08M 1.39% 35
2015
Q4
$988K Buy
25,090
+4,430
+21% +$185K 0.61% 57
2015
Q3
$824K Buy
20,660
+1,470
+8% +$63K 0.54% 63
2015
Q2
$921K Buy
19,190
+720
+4% +$36.4K 0.58% 59
2015
Q1
$892K Buy
+18,470
New +$884K 0.57% 61
2014
Q4
Sell
-6,450
Closed -$322K 104
2014
Q3
$322K Buy
+6,450
New +$341K 0.22% 81

Other funds holding IEMG

Boston Research & Management's IEMG Position: Q2 2026 in Review

Boston Research & Management reduced its iShares Core MSCI Emerging Markets ETF (IEMG) stake by 2.5% in Q2 2026, selling an estimated $204K and leaving 100,742 shares worth $8.35M. The position accounts for 1.84% of the portfolio, ranked #15.

Boston Research & Management first reported a position in IEMG in Q3 2014 and has held it in 47 quarters since. 2,409 funds tracked by Wall St. Rank hold IEMG as of Q2 2026.

  • Boston Research & Management held 100,742 shares of iShares Core MSCI Emerging Markets ETF worth $8.35M as of Q2 2026.
  • Boston Research & Management sold 2,564 iShares Core MSCI Emerging Markets ETF shares in Q2 2026, an estimated $204K.
  • iShares Core MSCI Emerging Markets ETF made up 1.84% of Boston Research & Management's portfolio in Q2 2026, its #15 holding.
  • Boston Research & Management first reported a position in iShares Core MSCI Emerging Markets ETF in Q3 2014 and has held it in 47 quarters since.
  • 2,409 funds tracked by Wall St. Rank held iShares Core MSCI Emerging Markets ETF as of Q2 2026.

Based on Boston Research & Management's 13F filing for Q2 2026, filed 11 Aug 2026.